Author information from the last article
Avdeling for blodsykdommer
Oslo universitetssykehus
og
Institutt for klinisk medisin
Universitetet i Oslo
Forfatterbidrag: revisjon av manuset.
Geir Erland Tjønnfjord er spesialist i blodsykdommer og indremedisin, avdelingsleder, seksjonsleder og professor.
Articles by Geir Erland Tjønnfjord
Allogeneic stem cell transplantation in adults 2015–21
- Camilla Dao Vo,
- Anders Eivind Myhre,
- Ingerid Weum Abrahamsen,
- Mats Remberger,
- Jonas Mattsson,
- Yngvar Fløisand,
- Bjørn Christer Linder Grønvold,
- Geir Erland Tjønnfjord,
- Tor Henrik Anderson Tvedt,
- Tobias Gedde-Dahl
14.03.2023:
Allogeneic stem cell transplantation is the only curative treatment for a number of malignant haematological diseases and congenital or acquired immunodeficiencies. In allogeneic stem cell transplantation, the patient's own bone marrow is destroyed following pre-transplant treatment with high-dose...
Therapeutic complement inhibition – from experimental to clinical medicine
- Knut Tore Lappegård,
- Anna Bjerre,
- Geir Erland Tjønnfjord,
- Tom Eirik Mollnes
20.10.2015:
The complement system plays a central part in the body's infection defence mechanism, but it is also involved in tissue homeostasis generally. Undesirable activation of the system occurs in connection with a number of diseases, so inhibition of the complement system has become an interesting...
Patient knowledge of late effects of acute lymphoblastic leukaemia
- Ellen Ruud,
- Adriani Kanellopoulos,
- Bernward Zeller,
- Eva Widing,
- Geir Erland Tjønnfjord,
- Sophie Dorothea Fosså
02.10.2012:
Cancer in children is rare, and accounts for only 1 % of all cancer incidences in Norway (1). Care for children with cancer is special because the patient is growing and developing, and most have the prospect of a long life after curative cancer treatment. The prognosis for children with cancer is...